ArticleClinical ophthalmology (Auckland, N.Z.)2020

Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial.

Steven Silverstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.